AAAAAA

   
Results: 1-3 |
Results: 3
IDOXIFENE, WHICH HAS A UNIQUE TISSUE-SPECIFIC MECHANISM, MAY PROVIDE A FAVORABLE ALTERNATIVE TO HORMONE REPLACEMENT THERAPY BY PREVENTING BONE LOSS AND INHIBITING BREAST-CANCER CELL-GROWTH
Authors: NUTTALL ME NADEAU DP PRICHETT WP GOWEN M
Citation: Me. Nuttall et al., IDOXIFENE, WHICH HAS A UNIQUE TISSUE-SPECIFIC MECHANISM, MAY PROVIDE A FAVORABLE ALTERNATIVE TO HORMONE REPLACEMENT THERAPY BY PREVENTING BONE LOSS AND INHIBITING BREAST-CANCER CELL-GROWTH, Journal of women's health, 7(5), 1998, pp. 626-626
SCREENING FOR HIGH-AFFINITY LIGANDS TO THE SRC SH2 DOMAIN USING CAPILLARY ISOELECTRIC FOCUSING-ELECTROSPRAY IONIZATION ION-TRAP MASS-SPECTROMETRY
Authors: LYUBARSKAYA YV CARR SA DUNNINGTON D PRICHETT WP FISHER SM APPELBAUM ER JONES CS KARGER BL
Citation: Yv. Lyubarskaya et al., SCREENING FOR HIGH-AFFINITY LIGANDS TO THE SRC SH2 DOMAIN USING CAPILLARY ISOELECTRIC FOCUSING-ELECTROSPRAY IONIZATION ION-TRAP MASS-SPECTROMETRY, Analytical chemistry (Washington), 70(22), 1998, pp. 4761-4770
IDOXIFENE, A TISSUE-SELECTIVE ESTROGEN AGONIST ANTAGONIST, HAS A MECHANISM OF ACTION IN BONE SIMILAR TO ESTROGEN AND DISTINCT FROM RALOXIFENE/
Authors: NUTTALL ME NADEAU D PRICHETT WP GOWEN M
Citation: Me. Nuttall et al., IDOXIFENE, A TISSUE-SELECTIVE ESTROGEN AGONIST ANTAGONIST, HAS A MECHANISM OF ACTION IN BONE SIMILAR TO ESTROGEN AND DISTINCT FROM RALOXIFENE/, Journal of bone and mineral research, 12, 1997, pp. 273-273
Risultati: 1-3 |